Trial intelligence / Profile preview

Citalopram for Bipolar Depression

NCT00562861Phase 3Completed

Sponsor
Tufts Medical Center
Start
Nov 2007
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of citalopram in bipolar disorder (BD), sponsored by Tufts Medical Center. Started Nov 2007; status: completed.

02

Drugs

citalopram
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00562861.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00562861.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call